We are live on ! Find out more
Royal Bank of Canada

Royal Bank of Canada Portfolio holdings

AUM $570B
1-Year Est. Return 27.57%
 

Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.

This Fund
S&P 500
This Quarter Est. Return
-13.35%
1 Year Est. Return
+27.57%
3 Year Est. Return
+75.99%
5 Year Est. Return
+94.97%
10 Year Est. Return
+325.25%
AUM
$340B
AUM Growth
-$60.4B
Cap. Flow
-$1.31B
Cap. Flow %
-0.39%
Top 10 Hldgs %
20.28%
Holding
8,274
New
398
Increased
2,517
Reduced
3,856
Closed
651

Sector Composition

Rank Sector Weight
1 Financials 20.3%
2 Technology 11.83%
3 Healthcare 8.85%
4 Energy 7.86%
5 Industrials 7.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NYMX
7801
DELISTED
Nymox Pharmaceutical Corp
NYMX
$0 ﹤0.01%
167
SQZ
7802
DELISTED
SQZ Biotechnologies Company
SQZ
-1,398
Closed -$7K
EVLO
7803
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
-114
Closed -$7K
JUGGW
7804
DELISTED
Jaws Juggernaut Acquisition Corporation Warrant
JUGGW
-23,503
Closed -$14K
JUGGU
7805
DELISTED
Jaws Juggernaut Acquisition Corporation Unit
JUGGU
-3,000
Closed -$30K
ONCR
7806
DELISTED
Oncorus, Inc.
ONCR
$0 ﹤0.01%
130
-1,125
-90% -$1.53K
HCNEW
7807
DELISTED
Jaws Hurricane Acquisition Corp. Warrant
HCNEW
-9,189
Closed -$7K
FNCH
7808
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
-16
Closed -$2K
SNRHU
7809
DELISTED
Senior Connect Acquisition Corp. I Unit
SNRHU
-30,884
Closed -$308K
MTVC.U
7810
DELISTED
Motive Capital Corp II Units, each consisting of one Class A ordinary share, and one-third of one redeemable warrant
MTVC.U
-74,698
Closed -$762K
WEJOW
7811
DELISTED
Wejo Group Limited Warrant
WEJOW
$0 ﹤0.01%
+479
New +$148
OIL
7812
DELISTED
iPath Pure Beta Crude Oil ETN
OIL
-300
Closed -$10K
SCUA.U
7813
DELISTED
Sculptor Acquisition Corp I Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
SCUA.U
-500
Closed -$5K
STSA
7814
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
-93
Closed
BPACU
7815
DELISTED
Bullpen Parlay Acquisition Company Unit
BPACU
-51,004
Closed -$511K
EOCW.WS
7816
DELISTED
Elliott Opportunity II Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
EOCW.WS
$0 ﹤0.01%
100
-9,900
-99% -$4.46K
ACOR
7817
DELISTED
Acorda Therapeutics
ACOR
$0 ﹤0.01%
15
-2
-12% -$36
BLCM
7818
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$0 ﹤0.01%
5
TCRR
7819
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$0 ﹤0.01%
143
-1,816
-93% -$4.48K
PNTM.U
7820
DELISTED
Pontem Corporation Units, each consisting of one Class A ordinary share, and one-third of one redeemable warrant
PNTM.U
-22,463
Closed -$222K
PSPC.U
7821
DELISTED
Post Holdings Partnering Corporation Units, each consisting of one share of Series A common stock, and one-third of one redeemable warrant
PSPC.U
-900
Closed -$9K
LABP
7822
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
$0 ﹤0.01%
34
-15
-31% -$136
VMGA
7823
DELISTED
VMG Consumer Acquisition Corp. Class A Common Stock
VMGA
-110
Closed -$1K
PGRW
7824
DELISTED
Progress Acquisition Corp. Class A Common Stock
PGRW
-1,000
Closed -$10K
EVOJU
7825
DELISTED
Evo Acquisition Corp. Unit
EVOJU
-1,773
Closed -$17K

Similar funds

Royal Bank of Canada's Q2 2022 Portfolio in Review

As of Q2 2022, Royal Bank of Canada held 8,274 positions worth $340B, down 15% from $400B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Royal Bank of Canada's Q2 2022 filing shows 398 new, 2,517 increased, 3,856 reduced and 651 closed positions. Its largest new stake was Aspen Technology Inc: 92,306 shares worth $17M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $558M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 20% a quarter earlier, followed by Technology and Healthcare.

  • Royal Bank of Canada's largest Q2 2022 buy was Aspen Technology Inc: 92,306 shares worth $17M.
  • Royal Bank of Canada added most to iShares Core S&P 500 ETF in Q2 2022, an estimated $866M increase.
  • Royal Bank of Canada's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $558M.
  • Royal Bank of Canada fully exited Discovery, Inc. Series C Common Stock in Q2 2022, selling an estimated $45.7M.
  • Royal Bank of Canada's ten largest holdings make up 20% of its $340B portfolio in Q2 2022.
  • Royal Bank of Canada opened 398 new positions and closed 651 in Q2 2022.
  • Royal Bank of Canada's portfolio value fell 15% quarter-over-quarter to $340B.

Based on Royal Bank of Canada's 13F filing for Q2 2022, filed 15 Aug 2022.